Scholarlink

Objective <p>To evaluate the efficacy of short-term spinal cord stimulation (stSCS) in promoting tracheal decannulation among patients with brain injury-induced disorders of consciousness(DoC).</p> Methods <p>A retrospective cohort study was conducted on 81 tracheotomized brain injury patients with DoC treated at Ganzhou People’s Hospital between June 2021 and June 2022.Patients were divided into two groups: the stSCS group (<i>n</i> = 46) receiving stSCS intervention and the control group (<i>n</i> = 35) receiving standard care. Decannulation success rates were compared using chi-square tests.</p> Results <p>The stSCS group demonstrated a significantly higher decannulation rate compared to the control group (50.0%vs.25.7%, χ²=5.24, <i>p</i> = 0.022).</p> Conclusion <p>stSCS significantly enhances tracheal decannulation success in brain injury patients with DoC, suggesting its potential as a therapeutic neuromodulation strategy.</p> Clinical trial number <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The short-term spinal cord stimulation improves the rates of tracheal decannulation in patients of brain injury with disorders of consciousness

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月26日

查看全文
  • Guanlin Huang,
  • Dong Wang,
  • Qiang Chen,
  • Qi Zhong,
  • Weilong Huang,
  • Xiaoping Zhou,
  • Qiuhua Jiang

摘要

Objective

To evaluate the efficacy of short-term spinal cord stimulation (stSCS) in promoting tracheal decannulation among patients with brain injury-induced disorders of consciousness(DoC).

Methods

A retrospective cohort study was conducted on 81 tracheotomized brain injury patients with DoC treated at Ganzhou People’s Hospital between June 2021 and June 2022.Patients were divided into two groups: the stSCS group (n = 46) receiving stSCS intervention and the control group (n = 35) receiving standard care. Decannulation success rates were compared using chi-square tests.

Results

The stSCS group demonstrated a significantly higher decannulation rate compared to the control group (50.0%vs.25.7%, χ²=5.24, p = 0.022).

Conclusion

stSCS significantly enhances tracheal decannulation success in brain injury patients with DoC, suggesting its potential as a therapeutic neuromodulation strategy.

Clinical trial number

Not applicable.